As a class of compounds the cannabinoids have huge therapeutic potential which has lead to extensive investigations. For over a decade ABS Laboratories have been using its validated assays to profile the pharmakinetics of these high profile molecules.
ABS laboratories offers GLP fully validated assays in a range of matrices and models for cannabidiol (CBD), Δ 9 – tetrahydrocannabinol (THC) and its metabolite11-hydroxy THC, and its tetrahydro cannabinvarin (THCV). ABS can develop bespoke assays for other cannabinoids as required.
In addition, it has extensive knowledge in the structural elucidation and identification of cannabinoids and their breakdown products in a range of cannabis based medicines and botanical raw materials using GC-MS and LC-MS/MS.
For any queries on the scope of the services provided please contact the business development team through the Quick Quotation link.